Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aetna
Aetna Shows Commitment to Patient Safety with 70 Percent Reduction in Refills of Duplicate Statin Prescriptions
June 27th, 2008
Aetna (NYSE:AET) announced the results of an internal study which show a 70 percent reduction in prescription duplication for members enrolled in its therapeutic duplication program. Launched in January 2007, the program is available to fully insured members taking the cholesterol-lowering statin class of medications and was designed to improve patient safety and reduce risk of serious side effects. Based on the results, Aetna has expanded the program to include additional drug classes. Therapeutic duplication (TD) can occur when two doctors are prescribing medications for the same patient. It can also occur when a doctor changes from one medication to another within...
Source: Health Business Week (2008-06-27)
|
